Madrigal Pharmaceuticals Inc - Company Profile

Powered by

All the sales intelligence you need on Madrigal Pharmaceuticals Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Madrigal Pharmaceuticals Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Madrigal Pharmaceuticals Inc.

Back to companies

Madrigal Pharmaceuticals Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

The following section provides information on Madrigal Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Madrigal Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Julian C. Baker

Chairman Executive Board Since: 2023 Age: 59

Mr. Julian C. Baker has been the Chairman of the company since 2023. Prior to this, he served as the Managing Member of Baker Brothers Investments. Mr. Baker also served as the Portfolio Manager at Tisch Financial Management.

Read Hide full bio of Julian C. Baker

Bill Sibold

Director; Chief Executive Officer Executive Board Since: 2023 Age: 59

Mr. Bill Sibold has been the Chief Executive Officer, and Director of the company since 2023. Prior to this, he served as the Executive Vice President, Specialty Care of Sanofi and President, Sanofi North America, Global Franchise Head Multiple Sclerosis. Mr. Sibold also served as the Senior Vice President, Global Franchise Head, Multiple Sclerosis, Oncology & Immunology at Sanofi Genzyme.

Read Hide full bio of Bill Sibold

Mardi C. Dier

Chief Financial Officer; Executive Vice President Senior Management Since: 2024 Age: 62

Ms. Mardi C. Dier has been the Chief Financial Officer and Senior Vice President of the company since 2024. Prior to this, she served as the Chief Financial Officer of Acelyrin Inc. Previously, she served as the Chief Financial Officer and Executive Vice President of Ultragenyx. Ms. Dier also served as the Chief Business Officer and Chief Financial Officer of Portola Pharmaceuticals.

Read Hide full bio of Mardi C. Dier

Ronald Filippo

Chief Information Officer; Executive Vice President Senior Management Since: 2023

Mr. Ronald Filippo has been the Chief Chief Information Officer of the company since 2023. Prior to this, he served as the Senior Vice President of Digital at Moderna. Previously, he served as the Head of Data and AI Transformation for North America at Teva Pharmaceuticals.

Read Hide full bio of Ronald Filippo

David Soergel

Executive Vice President; Chief Medical Officer Senior Management

Mr. David Soergel is the Executive Vice President and Chief Medical Officer of the company. Previously, he served as the Executive Vice President and Global Head of Cardiovascular at Novartis. Prior to Novartis, Dr. Soergel held leadership roles at biotechnology companies, including Senior Vice President of Clinical Development and Chief Medical Officer at Trevena.

Read Hide full bio of David Soergel
Gain a 360-degree view of Madrigal Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Madrigal Pharmaceuticals Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer